One of UK’s biggest trials, called Recovery, is evaluating the potential of Aspirin, commonly used as a blood thinner, as a possible treatment for coronavirus.
“Patients infected by the novel coronavirus are at a higher risk of blood clots because of hyper-reactive platelets, the cell fragments that help stop bleeding. Aspirin is an antiplatelet agent and can reduce the risk of clots,” the Recovery trial’s website said on Friday (November 6), reported Reuters.
“There is a clear rationale for believing that it (aspirin) might be beneficial, and it is safe, inexpensive and widely available,” said Peter Horby, co-chief investigator of the trial.
About 2,000 patients will be given 150 mg of aspirin besides the usual treatment daily. They will be compared with about 2,000 patients receiving the standard-of-care on its own, the website showed.